Publication | Closed Access

Inhibition of p38α MAPK enhances proteasome inhibitor-induced apoptosis of myeloma cells by modulating Hsp27, Bcl-XL, Mcl-1 and p53 levels in vitro and inhibits tumor growth in vivo

Tumor BiologyP53 LevelsMedicineApoptosisMyeloma CellsCancer Cell BiologyCell DeathP38α MapkAnti-cancer AgentRadiation OncologyCancer BiologyCell BiologyCell SignalingCancer Research